Literature DB >> 7782307

Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. Application of the mass isotopomer distribution analysis technique with testing of assumptions and potential problems.

R A Neese1, J M Schwarz, D Faix, S Turner, A Letscher, D Vu, M K Hellerstein.   

Abstract

We measured gluconeogenesis (GNG) in rats by mass isotopomer distribution analysis, which allows enrichment of the true biosynthetic precursor pool (hepatic cytosolic triose phosphates) to be determined. Fractional GNG from infused [3-13C]lactate, [1-13C]lactate, and [2-13C]glycerol was 88 +/- 2, 89 +/- 3, and 87 +/- 2%, respectively, after 48 h of fasting. [2-13C]Glycerol was the most efficient label and allowed measurement of rate of appearance of intrahepatic triose phosphate (Ra triose-P), by dilution. IV fructose (10-15 mg/kg/min) increased absolute GNG by 81-147%. Ra triose-P increased proportionately, but endogenous Ra triose-P was almost completely suppressed, suggesting feedback control. Interestingly, 15-17% of fructose was directly converted to glucose without entering hepatic triose-P. IV glucose reduced GNG and Ra triose-P. 24-h fasting reduced hepatic glucose production by half, but absolute GNG was unchanged due to increased fractional GNG (51-87%). Reduced hepatic glucose production was entirely due to decreased glycogen input, from 7.3 +/- 1.8 to 1.1 +/- 0.2 mg/kg/min. Ra triose-P fell during fasting, but efficiency of triose-P disposal into GNG increased, maintaining GNG constant. Secreted glucuronyl conjugates and plasma glucose results correlated closely. In summary, GNG and intrahepatic triose-P flux can be measured by mass isotopomer distribution analysis with [2-13C]glycerol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782307     DOI: 10.1074/jbc.270.24.14452

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study.

Authors:  M K Hellerstein; R A Neese; P Linfoot; M Christiansen; S Turner; A Letscher
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Molecular ion fragmentation and its effects on mass isotopomer abundances of fatty acid methyl esters ionized by electron impact.

Authors:  C K Fagerquist; R A Neese; M K Hellerstein
Journal:  J Am Soc Mass Spectrom       Date:  1999-05       Impact factor: 3.109

Review 3.  Synthesis of fat in response to alterations in diet: insights from new stable isotope methodologies.

Authors:  M K Hellerstein
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.

Authors:  C Beysen; E J Murphy; K Deines; M Chan; E Tsang; A Glass; S M Turner; J Protasio; T Riiff; M K Hellerstein
Journal:  Diabetologia       Date:  2011-12-02       Impact factor: 10.122

5.  Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: studies in vitro, in animals, and in humans.

Authors:  D C Macallan; C A Fullerton; R A Neese; K Haddock; S S Park; M K Hellerstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

6.  Contributions of gluconeogenesis to glucose production in the fasted state.

Authors:  B R Landau; J Wahren; V Chandramouli; W C Schumann; K Ekberg; S C Kalhan
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Real-time detection of hepatic gluconeogenic and glycogenolytic states using hyperpolarized [2-13C]dihydroxyacetone.

Authors:  Karlos X Moreno; Santhosh Satapati; Ralph J DeBerardinis; Shawn C Burgess; Craig R Malloy; Matthew E Merritt
Journal:  J Biol Chem       Date:  2014-10-28       Impact factor: 5.157

8.  The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.

Authors:  Kathleen Mulligan; Hootan Khatami; Jean-Marc Schwarz; Giorgos K Sakkas; Alex M DePaoli; Viva W Tai; Michael J Wen; Grace A Lee; Carl Grunfeld; Morris Schambelan
Journal:  J Clin Endocrinol Metab       Date:  2009-01-27       Impact factor: 5.958

9.  Short-term effects of recombinant human growth hormone and feeding on gluconeogenesis in humans.

Authors:  Walid Kaplan; Agneta L Sunehag; Harry Dao; Morey W Haymond
Journal:  Metabolism       Date:  2008-06       Impact factor: 8.694

10.  Interaction between the pentose phosphate pathway and gluconeogenesis from glycerol in the liver.

Authors:  Eunsook S Jin; A Dean Sherry; Craig R Malloy
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.